Copyright Reports & Markets. All rights reserved.

Global Hemoglobinopathy Treatment Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Hemoglobinopathy Treatment Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Hydroxyurea
      • 1.4.3 Glutamine
      • 1.4.4 Zynteglo
      • 1.4.5 Other
    • 1.5 Market by Application
      • 1.5.1 Global Hemoglobinopathy Treatment Market Share by Application (2019-2025)
      • 1.5.2 Sickle Cell Diseases
      • 1.5.3 Thalassemia
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Hemoglobinopathy Treatment Market Size
    • 2.2 Hemoglobinopathy Treatment Growth Trends by Regions
      • 2.2.1 Hemoglobinopathy Treatment Market Size by Regions (2019-2025)
      • 2.2.2 Hemoglobinopathy Treatment Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Hemoglobinopathy Treatment Market Size by by Players
      • 3.1.1 Global Hemoglobinopathy Treatment Revenue by by Players (2014-2019)
      • 3.1.2 Global Hemoglobinopathy Treatment Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Hemoglobinopathy Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Hemoglobinopathy Treatment Key Players Head office and Area Served
    • 3.3 Key Players Hemoglobinopathy Treatment Product/Solution/Service
    • 3.4 Date of Enter into Hemoglobinopathy Treatment Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Hemoglobinopathy Treatment Market Size by Type (2014-2019)
    • 4.2 Global Hemoglobinopathy Treatment Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Hemoglobinopathy Treatment Market Size (2014-2019)
    • 5.2 Hemoglobinopathy Treatment Key Players in North America
    • 5.3 North America Hemoglobinopathy Treatment Market Size by Type
    • 5.4 North America Hemoglobinopathy Treatment Market Size by Application

    6 Europe

    • 6.1 Europe Hemoglobinopathy Treatment Market Size (2014-2019)
    • 6.2 Hemoglobinopathy Treatment Key Players in Europe
    • 6.3 Europe Hemoglobinopathy Treatment Market Size by Type
    • 6.4 Europe Hemoglobinopathy Treatment Market Size by Application

    7 China

    • 7.1 China Hemoglobinopathy Treatment Market Size (2014-2019)
    • 7.2 Hemoglobinopathy Treatment Key Players in China
    • 7.3 China Hemoglobinopathy Treatment Market Size by Type
    • 7.4 China Hemoglobinopathy Treatment Market Size by Application

    8 Japan

    • 8.1 Japan Hemoglobinopathy Treatment Market Size (2014-2019)
    • 8.2 Hemoglobinopathy Treatment Key Players in Japan
    • 8.3 Japan Hemoglobinopathy Treatment Market Size by Type
    • 8.4 Japan Hemoglobinopathy Treatment Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Hemoglobinopathy Treatment Market Size (2014-2019)
    • 9.2 Hemoglobinopathy Treatment Key Players in Southeast Asia
    • 9.3 Southeast Asia Hemoglobinopathy Treatment Market Size by Type
    • 9.4 Southeast Asia Hemoglobinopathy Treatment Market Size by Application

    10 India

    • 10.1 India Hemoglobinopathy Treatment Market Size (2014-2019)
    • 10.2 Hemoglobinopathy Treatment Key Players in India
    • 10.3 India Hemoglobinopathy Treatment Market Size by Type
    • 10.4 India Hemoglobinopathy Treatment Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Hemoglobinopathy Treatment Market Size (2014-2019)
    • 11.2 Hemoglobinopathy Treatment Key Players in Central & South America
    • 11.3 Central & South America Hemoglobinopathy Treatment Market Size by Type
    • 11.4 Central & South America Hemoglobinopathy Treatment Market Size by Application

    12 International Players Profiles

    • 12.1 Novartis
      • 12.1.1 Novartis Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Hemoglobinopathy Treatment Introduction
      • 12.1.4 Novartis Revenue in Hemoglobinopathy Treatment Business (2014-2019))
      • 12.1.5 Novartis Recent Development
    • 12.2 AstraZeneca
      • 12.2.1 AstraZeneca Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Hemoglobinopathy Treatment Introduction
      • 12.2.4 AstraZeneca Revenue in Hemoglobinopathy Treatment Business (2014-2019)
      • 12.2.5 AstraZeneca Recent Development
    • 12.3 Bluebird
      • 12.3.1 Bluebird Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Hemoglobinopathy Treatment Introduction
      • 12.3.4 Bluebird Revenue in Hemoglobinopathy Treatment Business (2014-2019)
      • 12.3.5 Bluebird Recent Development
    • 12.4 Bristol-Myers Squibb
      • 12.4.1 Bristol-Myers Squibb Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Hemoglobinopathy Treatment Introduction
      • 12.4.4 Bristol-Myers Squibb Revenue in Hemoglobinopathy Treatment Business (2014-2019)
      • 12.4.5 Bristol-Myers Squibb Recent Development
    • 12.5 Emmaus Medical
      • 12.5.1 Emmaus Medical Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Hemoglobinopathy Treatment Introduction
      • 12.5.4 Emmaus Medical Revenue in Hemoglobinopathy Treatment Business (2014-2019)
      • 12.5.5 Emmaus Medical Recent Development
    • 12.6 Acceleron Pharma
      • 12.6.1 Acceleron Pharma Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Hemoglobinopathy Treatment Introduction
      • 12.6.4 Acceleron Pharma Revenue in Hemoglobinopathy Treatment Business (2014-2019)
      • 12.6.5 Acceleron Pharma Recent Development
    • 12.7 HemaQuest Pharmaceuticals
      • 12.7.1 HemaQuest Pharmaceuticals Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Hemoglobinopathy Treatment Introduction
      • 12.7.4 HemaQuest Pharmaceuticals Revenue in Hemoglobinopathy Treatment Business (2014-2019)
      • 12.7.5 HemaQuest Pharmaceuticals Recent Development
    • 12.8 Eli Lilly and Company
      • 12.8.1 Eli Lilly and Company Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Hemoglobinopathy Treatment Introduction
      • 12.8.4 Eli Lilly and Company Revenue in Hemoglobinopathy Treatment Business (2014-2019)
      • 12.8.5 Eli Lilly and Company Recent Development
    • 12.9 Celgene
      • 12.9.1 Celgene Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Hemoglobinopathy Treatment Introduction
      • 12.9.4 Celgene Revenue in Hemoglobinopathy Treatment Business (2014-2019)
      • 12.9.5 Celgene Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      This report focuses on the global Hemoglobinopathy Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hemoglobinopathy Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      Novartis
      AstraZeneca
      Bluebird
      Bristol-Myers Squibb
      Emmaus Medical
      Acceleron Pharma
      HemaQuest Pharmaceuticals
      Eli Lilly and Company
      Celgene

      Market segment by Type, the product can be split into
      Hydroxyurea
      Glutamine
      Zynteglo
      Other

      Market segment by Application, split into
      Sickle Cell Diseases
      Thalassemia

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Hemoglobinopathy Treatment status, future forecast, growth opportunity, key market and key players.
      To present the Hemoglobinopathy Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Hemoglobinopathy Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
      Buy now